prepared in collaboration with the
WHO Collaborating Centre for
International Drug Monitoring,
Uppsala, Sweden
The aim of this Newsletter is to disseminate information on the safety and efficacy of pharmaceutical products, based on information received from our network of “drug information officers” and other sources such as specialized bulletins and journals, as well as partners in WHO. The information is produced in the form of resumes in English full texts of which may be obtained on request from:
Quality Assurance and Safety:
Medicines, EDM-HTP
World Health Organization,
1211 Geneva 27, Switzerland
E-mail address: QSM@who.int
Fax: +41 22 791 4730
Further information on adverse reactions may be obtained from the
WHO Collaborating Centre for International Drug Monitoring,
Stora Target 3,
S-753 20 Uppsala, Sweden
Tel: 46-18-65.60.60
Fax: 46-18-65.60.80
E-mail: sten.olsson@who-umc.se
Internet: http://www.who-umc.org
Loading...
